The use of paediatric chemotherapy protocols at full dose is both a rational and feasible treatment strategy in adults with Ewing's family tumours
Open Access
- 1 November 1997
- journal article
- Published by Elsevier in Annals of Oncology
- Vol. 8 (11) , 1099-1105
- https://doi.org/10.1023/a:1008264902857
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Long-term results from the first UKCCSG Ewing's tumour study (ET-1)European Journal Of Cancer, 1997
- The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric TranscriptsNew England Journal of Medicine, 1994
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.Journal of Clinical Oncology, 1993
- Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's SarcomaJNCI Journal of the National Cancer Institute, 1991
- The impact of doxorubicin dose intensity on survival of patients with Ewing's sarcoma.Journal of Clinical Oncology, 1991
- Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.Journal of Clinical Oncology, 1990
- Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.Journal of Clinical Oncology, 1990
- Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases and remarkable consistency of t(11;22)(q24;q12)Cancer Genetics and Cytogenetics, 1988
- Multidisciplinary treatment of primary Ewing's sarcoma of bone.A 6-year experience of a European cooperative trialCancer, 1988
- Incidence of bone sarcoma in SW England, 1946-74, in relation to age, sex, tumour site and histologyBritish Journal of Cancer, 1977